JP2010529958A5 - - Google Patents

Download PDF

Info

Publication number
JP2010529958A5
JP2010529958A5 JP2010510812A JP2010510812A JP2010529958A5 JP 2010529958 A5 JP2010529958 A5 JP 2010529958A5 JP 2010510812 A JP2010510812 A JP 2010510812A JP 2010510812 A JP2010510812 A JP 2010510812A JP 2010529958 A5 JP2010529958 A5 JP 2010529958A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
group
disease
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010510812A
Other languages
English (en)
Japanese (ja)
Other versions
JP5671678B2 (ja
JP2010529958A (ja
Filing date
Publication date
Priority claimed from EP07109652A external-priority patent/EP2027889A1/en
Application filed filed Critical
Publication of JP2010529958A publication Critical patent/JP2010529958A/ja
Publication of JP2010529958A5 publication Critical patent/JP2010529958A5/ja
Application granted granted Critical
Publication of JP5671678B2 publication Critical patent/JP5671678B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010510812A 2007-06-05 2008-06-05 ニューロン生存因子およびその使用 Active JP5671678B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07109652A EP2027889A1 (en) 2007-06-05 2007-06-05 New neuronal viability factor and use thereof
EP07109652.3 2007-06-05
PCT/EP2008/057031 WO2008148860A1 (en) 2007-06-05 2008-06-05 New neuronal viability factor and use thereof

Publications (3)

Publication Number Publication Date
JP2010529958A JP2010529958A (ja) 2010-09-02
JP2010529958A5 true JP2010529958A5 (https=) 2011-07-21
JP5671678B2 JP5671678B2 (ja) 2015-02-18

Family

ID=38573348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010510812A Active JP5671678B2 (ja) 2007-06-05 2008-06-05 ニューロン生存因子およびその使用

Country Status (5)

Country Link
US (5) US9575075B2 (https=)
EP (2) EP2027889A1 (https=)
JP (1) JP5671678B2 (https=)
ES (1) ES2623464T3 (https=)
WO (1) WO2008148860A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7261544B2 (en) 2003-05-21 2007-08-28 Genzyme Corporation Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
EP2027889A1 (en) * 2007-06-05 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) New neuronal viability factor and use thereof
EP2281047B1 (en) 2008-04-15 2020-04-08 Genzyme Corporation Methods to produce rod-derived cone viability factor (rdcvf)
EP2383286A1 (en) 2010-04-30 2011-11-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
CA2853379C (en) 2011-10-27 2020-11-24 Wellstat Ophthalmics Corporation Vectors encoding rod-derived cone viability factor
US9265786B1 (en) * 2012-03-30 2016-02-23 University Of Wyoming Method for reducing protein misfolding and accumulation in Huntington'S disease cells
JP6684343B2 (ja) 2015-05-21 2020-04-22 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル ニューロン生存因子の相乗組み合わせ及びその使用
KR20230156440A (ko) 2016-10-11 2023-11-14 웰스테이트 옵탈믹스 코퍼레이션 짧은 형태의 간상체 유래 원추체 생존능 인자와 친수성 펩타이드 사이의 융합 단백질
WO2018134168A1 (en) 2017-01-17 2018-07-26 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of expressing a polynucleotide of interest in the cone photoreceptors
CN111867635A (zh) 2017-10-20 2020-10-30 法国国家卫生及研究医学协会 包括视网膜下递送治疗有效量的重组aav9衍生载体的在对象的视锥细胞光感受器中表达目的多核苷酸的方法
SG11202006796RA (en) 2017-12-22 2020-08-28 Sparingvision Constructs comprising neuronal viability factors and uses thereof
WO2022223644A2 (en) 2021-04-20 2022-10-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for treating retinal degenerative disorders
US20250276088A1 (en) * 2021-07-07 2025-09-04 Institut National de la Santé et de la Recherche Médicale Synergistic combination of rdcfv2 and rdcvf2l for the treatment of tauopathies
IL320351A (en) 2022-10-20 2025-06-01 Sparingvision Compositions and methods for treating retinal degenerative disorders
KR20260008735A (ko) 2023-03-30 2026-01-16 파마 싱크, 엘엘씨 간상체-유래 원뿔세포 생존인자 및 인간 IgK 신호 서열을 인코딩하는 벡터

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2402563A1 (en) 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
FR2823221B1 (fr) * 2001-04-06 2004-04-02 Univ Pasteur Sequences associees a la degenerescence retinienne et applications
FR2870241B1 (fr) * 2004-05-13 2015-02-27 Novartis Ag Facteur de viabilite des cones derive des batonnets ou rdcvf et applications
WO2008137066A1 (en) * 2007-05-02 2008-11-13 The Board Of Regents Of The University Of Oklahoma Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases
EP2027889A1 (en) * 2007-06-05 2009-02-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) New neuronal viability factor and use thereof
ES2582559T3 (es) * 2007-12-06 2016-09-13 Inserm - Institut National De La Santé Et De La Recherche Médicale Factor trófico para el tratamiento de las enfermedades degenerativas de la retina
US8779093B2 (en) * 2008-09-10 2014-07-15 Inserm (Institut National De La Sante Et De La Recherche Medicale) Neuronal viability factor and use thereof
CA2853379C (en) * 2011-10-27 2020-11-24 Wellstat Ophthalmics Corporation Vectors encoding rod-derived cone viability factor
JP6684343B2 (ja) * 2015-05-21 2020-04-22 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル ニューロン生存因子の相乗組み合わせ及びその使用
CN111867635A (zh) * 2017-10-20 2020-10-30 法国国家卫生及研究医学协会 包括视网膜下递送治疗有效量的重组aav9衍生载体的在对象的视锥细胞光感受器中表达目的多核苷酸的方法
SG11202006796RA (en) * 2017-12-22 2020-08-28 Sparingvision Constructs comprising neuronal viability factors and uses thereof

Similar Documents

Publication Publication Date Title
JP2010529958A5 (https=)
Fang et al. Adaptations to a subterranean environment and longevity revealed by the analysis of mole rat genomes
AU2024201282A1 (en) Compositions and methods for treating autoimmune diseases and cancers
JP6280222B2 (ja) サルモネラ菌の非コードｒｎａおよびその同定と使用
RS64769B1 (sr) Varijante adeno-asociranih virusa i postupci upotrebe
Hartl et al. Cis-regulatory landscapes of four cell types of the retina
Li et al. Maize transcription factor ZmARF4 confers phosphorus tolerance by promoting root morphological development
Xu et al. The soil emergence-related transcription factor PIF3 controls root penetration by interacting with the receptor kinase FER
US20220235102A1 (en) Specific nuclear-anchored independent labeling system
Wu et al. Transcriptome analysis of different sizes of 3‐mercaptopropionic acid‐modified cadmium telluride quantum dot‐induced toxic effects reveals immune response in rat hippocampus
US20250154498A1 (en) Reagents for subcellular delivery of cargo to target cells
CN110760511B (zh) 一种用于治疗杜氏肌营养不良症的gRNA、表达载体、CRISPR-Cas9系统
CN113711046A (zh) 用于揭示与Tau聚集相关的基因脆弱性的CRISPR/Cas脱落筛选平台
Denvir et al. Whole genome sequence analysis of the TALLYHO/Jng mouse
Lucibelli et al. Extending the toolkit for beauty: Differential co-expression of DROOPING LEAF-like and class B MADS-Box genes during Phalaenopsis flower development
WO2023143150A1 (zh) 新型Cas酶和系统以及应用
US20060003959A1 (en) Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same
Brimacombe et al. Cloning and embryonic expression patterns of the chicken CELF family
CN108779495A (zh) 调节bckdh的方法
Tian et al. Comparative genomics provides insights into chromosomal evolution and immunological adaptation in horseshoe bats
CN115867678A (zh) 鉴定和表征指环病毒的方法及其用途
CN109134633A (zh) 抗稻瘟病蛋白和基因、分离的核酸及其应用
JP2016534752A (ja) 酸化ストレス、およびｄｎａに対する損傷によって引き起こされる疾患を処置するための、ｇｓｅ２４．２に由来するペプチド
CN1914336B (zh) 犬骨关节炎相关基因及相关的方法和组合物
KR102533992B1 (ko) 세포에의 외래 유전자 도입 확인 방법 및 외래 유전자 도입 세포의 제조 방법